<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>66(8)</volume><submitter>Wagner K</submitter><pubmed_abstract>&lt;h4>Objective&lt;/h4>What factors influence cognition and behavior in patients with epilepsy caused by hypothalamic hamartoma (HH)?&lt;h4>Methods&lt;/h4>We conducted a retrospective study of 103 patients referred to the Epilepsy Center in Freiburg, Germany, over the past 24 years. Analyzed parameters included development/intellectual functioning, behavior, seizure types and frequency, as well as electroencephalography (EEG) and magnetic resonance imaging (MRI) analyses.&lt;h4>Results&lt;/h4>Half of the patients showed signs of global developmental delay (GDD) or intellectual disability (ID). Patients with GDD/ID were younger at epilepsy onset (p &lt; .05) and at first referral (p &lt; .001), had shorter disease durations (p &lt; .01), experienced more frequent seizures (p &lt; .001), and were prescribed more antiseizure medication (ASM; p &lt; .01). They also had larger HH volumes (hamartoma types Delalande III and IV, both p &lt; .001) and more frequent pathological EEG background activity (p &lt; .001), as well as more extended interictal epileptiform discharges (IEDs; p &lt; .05, the rate of IED and seizure types were comparable, p > .05). Of interest, pathological EEG background activity and HH type were the only predictors of GDD/ID resulting in a highly predictive model (R&lt;sup>2&lt;/sup> = 0.75, p &lt; .001). Patients with GDD/ID also experienced more externalized behavioral problems, particularly aggression, which was predicted only by EEG background activity (R&lt;sup>2&lt;/sup> = 0.36, p &lt; .001). None of the epilepsy-specific parameters, such as duration and seizure type or frequency, were significant predictors.&lt;h4>Significance&lt;/h4>Our findings support the idea that patients with epilepsy due to HH and GDD/ID may have a more severe underlying condition with a likely genetic etiology, characterized by developmental and epileptic encephalopathy.</pubmed_abstract><journal>Epilepsia</journal><pagination>2894-2903</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12371641</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Developmental and epileptic encephalopathy in patients with epilepsy due to hypothalamic hamartomas.</pubmed_title><pmcid>PMC12371641</pmcid><pubmed_authors>Metzger S</pubmed_authors><pubmed_authors>Niedermoser F</pubmed_authors><pubmed_authors>Urbach H</pubmed_authors><pubmed_authors>Schulze-Bonhage A</pubmed_authors><pubmed_authors>Putzar L</pubmed_authors><pubmed_authors>Wagner K</pubmed_authors><pubmed_authors>Demerath T</pubmed_authors><pubmed_authors>Metternich B</pubmed_authors><pubmed_authors>San Antonio-Arce V</pubmed_authors><pubmed_authors>Klotz KA</pubmed_authors></additional><is_claimable>false</is_claimable><name>Developmental and epileptic encephalopathy in patients with epilepsy due to hypothalamic hamartomas.</name><description>&lt;h4>Objective&lt;/h4>What factors influence cognition and behavior in patients with epilepsy caused by hypothalamic hamartoma (HH)?&lt;h4>Methods&lt;/h4>We conducted a retrospective study of 103 patients referred to the Epilepsy Center in Freiburg, Germany, over the past 24 years. Analyzed parameters included development/intellectual functioning, behavior, seizure types and frequency, as well as electroencephalography (EEG) and magnetic resonance imaging (MRI) analyses.&lt;h4>Results&lt;/h4>Half of the patients showed signs of global developmental delay (GDD) or intellectual disability (ID). Patients with GDD/ID were younger at epilepsy onset (p &lt; .05) and at first referral (p &lt; .001), had shorter disease durations (p &lt; .01), experienced more frequent seizures (p &lt; .001), and were prescribed more antiseizure medication (ASM; p &lt; .01). They also had larger HH volumes (hamartoma types Delalande III and IV, both p &lt; .001) and more frequent pathological EEG background activity (p &lt; .001), as well as more extended interictal epileptiform discharges (IEDs; p &lt; .05, the rate of IED and seizure types were comparable, p > .05). Of interest, pathological EEG background activity and HH type were the only predictors of GDD/ID resulting in a highly predictive model (R&lt;sup>2&lt;/sup> = 0.75, p &lt; .001). Patients with GDD/ID also experienced more externalized behavioral problems, particularly aggression, which was predicted only by EEG background activity (R&lt;sup>2&lt;/sup> = 0.36, p &lt; .001). None of the epilepsy-specific parameters, such as duration and seizure type or frequency, were significant predictors.&lt;h4>Significance&lt;/h4>Our findings support the idea that patients with epilepsy due to HH and GDD/ID may have a more severe underlying condition with a likely genetic etiology, characterized by developmental and epileptic encephalopathy.</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Aug</publication><modification>2026-05-09T10:39:10.371Z</modification><creation>2026-04-08T00:48:04.165Z</creation></dates><accession>S-EPMC12371641</accession><cross_references><pubmed>40207589</pubmed><doi>10.1111/epi.18404</doi></cross_references></HashMap>